145 related articles for article (PubMed ID: 20554312)
1. A functional matrix metalloproteinase (MMP)-9 polymorphism modifies plasma MMP-9 levels in subjects environmentally exposed to mercury.
Jacob-Ferreira AL; Passos CJ; Gerlach RF; Barbosa F; Tanus-Santos JE
Sci Total Environ; 2010 Sep; 408(19):4085-92. PubMed ID: 20554312
[TBL] [Abstract][Full Text] [Related]
2. A common matrix metalloproteinase (MMP)-2 polymorphism affects plasma MMP-2 levels in subjects environmentally exposed to mercury.
Jacob-Ferreira AL; Lacchini R; Gerlach RF; Passos CJ; Barbosa F; Tanus-Santos JE
Sci Total Environ; 2011 Sep; 409(20):4242-6. PubMed ID: 21794897
[TBL] [Abstract][Full Text] [Related]
3. Mercury exposure increases circulating net matrix metalloproteinase (MMP)-2 and MMP-9 activities.
Jacob-Ferreira AL; Passos CJ; Jordão AA; Fillion M; Mergler D; Lemire M; Gerlach RF; Barbosa F; Tanus-Santos JE
Basic Clin Pharmacol Toxicol; 2009 Oct; 105(4):281-8. PubMed ID: 19594729
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-9 genetic variations affect MMP-9 levels in obese children.
Belo VA; Souza-Costa DC; Luizon MR; Lanna CM; Carneiro PC; Izidoro-Toledo TC; Ferraz KC; Tanus-Santos JE
Int J Obes (Lond); 2012 Jan; 36(1):69-75. PubMed ID: 21844877
[TBL] [Abstract][Full Text] [Related]
5. Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis.
Bauvois B; Mothu N; Nguyen J; Nguyen-Khoa T; Nöel LH; Jungers P
Nephrol Dial Transplant; 2007 Apr; 22(4):1115-22. PubMed ID: 17205957
[TBL] [Abstract][Full Text] [Related]
6. Functional matrix metalloproteinase (MMP)-9 genetic variants modify the effects of hemodialysis on circulating MMP-9 levels.
Marson BP; Lacchini R; Belo V; Mattos SG; da Costa BP; Poli-de-Figueiredo CE; Tanus-Santos JE
Clin Chim Acta; 2012 Dec; 414():46-51. PubMed ID: 23010359
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms.
Nanni S; Melandri G; Hanemaaijer R; Cervi V; Tomasi L; Altimari A; Van Lent N; Tricoci P; Bacchi L; Branzi A
Transl Res; 2007 Mar; 149(3):137-44. PubMed ID: 17320799
[TBL] [Abstract][Full Text] [Related]
8. Assessment of matrix metalloproteinase (MMP)-2, MMP-8, MMP-9, and their inhibitors, the tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in obese children and adolescents.
Belo VA; Souza-Costa DC; Lana CM; Caputo FL; Marcaccini AM; Gerlach RF; Bastos MG; Tanus-Santos JE
Clin Biochem; 2009 Jul; 42(10-11):984-90. PubMed ID: 19358835
[TBL] [Abstract][Full Text] [Related]
9. Plasma MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 during human orthotopic liver transplantation. The effect of aprotinin and the relation to ischemia/reperfusion injury.
Kuyvenhoven JP; Molenaar IQ; Verspaget HW; Veldman MG; Palareti G; Legnani C; Moolenburgh SE; Terpstra OT; Lamers CB; van Hoek B; Porte RJ
Thromb Haemost; 2004 Mar; 91(3):506-13. PubMed ID: 14983226
[TBL] [Abstract][Full Text] [Related]
10. A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patients.
Demacq C; Vasconcellos VB; Marcaccini AM; Gerlach RF; Machado AA; Tanus-Santos JE
Pharmacogenomics J; 2009 Aug; 9(4):265-73. PubMed ID: 19381161
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms of the matrix metalloproteinase-3 (MMP-3) and tissue inhibitors of matrix metalloproteinases-1 (TIMP-1) modulate the development of ankylosing spondylitis.
Wei JC; Lee HS; Chen WC; Shiu LJ; Yang SF; Wong RH
Ann Rheum Dis; 2009 Nov; 68(11):1781-6. PubMed ID: 19019896
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphism of matrix metalloproteinase (MMP)-9 does not affect plasma MMP-9 activity in healthy subjects.
Demacq C; de Souza AP; Machado AA; Gerlach RF; Tanus-Santos JE
Clin Chim Acta; 2006 Mar; 365(1-2):183-7. PubMed ID: 16168399
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-9 activity in plasma correlates with plasma and whole blood lead concentrations.
Barbosa F; Gerlach RF; Tanus-Santos JE
Basic Clin Pharmacol Toxicol; 2006 Jun; 98(6):559-64. PubMed ID: 16700817
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the MMP-9 (C-1562 T) and TIMP-2 (G-418C) gene promoter polymorphisms in patients with chronic periodontitis.
de Souza AP; Trevilatto PC; Scarel-Caminaga RM; de Brito RB; Barros SP; Line SR
J Clin Periodontol; 2005 Feb; 32(2):207-11. PubMed ID: 15691353
[TBL] [Abstract][Full Text] [Related]
15. Elevated matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in obese children and adolescents.
Głowińska-Olszewska B; Urban M
Metabolism; 2007 Jun; 56(6):799-805. PubMed ID: 17512313
[TBL] [Abstract][Full Text] [Related]
16. Circulating matrix metalloproteinase-8 (MMP-8) and MMP-9 are increased in chronic periodontal disease and decrease after non-surgical periodontal therapy.
Marcaccini AM; Novaes AB; Meschiari CA; Souza SL; Palioto DB; Sorgi CA; Faccioli LH; Tanus-Santos JE; Gerlach RF
Clin Chim Acta; 2009 Nov; 409(1-2):117-22. PubMed ID: 19751716
[TBL] [Abstract][Full Text] [Related]
17. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
[TBL] [Abstract][Full Text] [Related]
18. Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome.
Gonçalves FM; Jacob-Ferreira AL; Gomes VA; Casella-Filho A; Chagas AC; Marcaccini AM; Gerlach RF; Tanus-Santos JE
Clin Chim Acta; 2009 May; 403(1-2):173-7. PubMed ID: 19254704
[TBL] [Abstract][Full Text] [Related]
19. Increases in circulating matrix metalloproteinase-9 levels following fibrinolysis for acute pulmonary embolism.
Mühl D; Ghosh S; Uzuelli JA; Lantos J; Tanus-Santos JE
Thromb Res; 2010 Jun; 125(6):549-53. PubMed ID: 20307903
[TBL] [Abstract][Full Text] [Related]
20. Specific matrix metalloproteinase 9 (MMP-9) haplotype affect the circulating MMP-9 levels in women with migraine.
Martins-Oliveira A; Gonçalves FM; Speciali JG; Fontana V; Izidoro-Toledo TC; Belo VA; Dach F; Tanus-Santos JE
J Neuroimmunol; 2012 Nov; 252(1-2):89-94. PubMed ID: 22907074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
